Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- NARA ID
- audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Audit
- Released
- 2020-09-29
- Slug
- doj-oig-audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Indexed
- 2026-04-27 05:03:38
More from DOJ OIG — Drug Enforcement Administration
- Investigative Summary: Findings of Misconduct by a then Drug Enforcement Administration Assistant Special Agent in Charge for Having an Inappropriate, Intimate Relationship with a Subordinate, Obstruction, Lack of Candor, and Related Misconduct
- Bonuses and Other Favorable Personnel Actions for Drug Enforcement Administration Employees Involved in Alleged Sexual Misconduct Incidents Referenced in the OIG's March 2015 Report
- Audit of the Drug Enforcement Administration's Income-Generating, Undercover Operations
- Review of the Drug Enforcement Administration's El Paso Intelligence Center
- Audit of the Drug Enforcement Administration's Adoptive Seizure Process and Status of Related Equitable Sharing Requests
- Procedural Reform Recommendation for the U.S. Marshals Service, Superior Court of the District of Columbia
Browse all 58 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.